These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38874041)

  • 41. A deep neural network predictor to predict the sensitivity of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Liu Y; Shi J; Liu W; Tang Y; Shu X; Wang R; Chen Y; Shi X; Jin J; Li D
    Cancer Lett; 2024 May; 589():216641. PubMed ID: 38232812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Comprehensive Prediction Model Based on MRI Radiomics and Clinical Factors to Predict Tumor Response After Neoadjuvant Chemoradiotherapy in Rectal Cancer.
    Jiang H; Guo W; Yu Z; Lin X; Zhang M; Jiang H; Zhang H; Sun Z; Li J; Yu Y; Zhao S; Hu H
    Acad Radiol; 2023 Sep; 30 Suppl 1():S185-S198. PubMed ID: 37394412
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The split scar sign as an indicator of sustained complete response after neoadjuvant therapy in rectal cancer.
    Santiago I; Barata M; Figueiredo N; Parés O; Henriques V; Galzerano A; Carvalho C; Matos C; Heald RJ
    Eur Radiol; 2020 Jan; 30(1):224-238. PubMed ID: 31350587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer.
    Ippolito D; Drago SG; Pecorelli A; Maino C; Querques G; Mariani I; Franzesi CT; Sironi S
    World J Gastroenterol; 2020 May; 26(20):2657-2668. PubMed ID: 32523318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Machine learning in predicting pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer using MRI: a systematic review and meta-analysis.
    He J; Wang SX; Liu P
    Br J Radiol; 2024 Jun; 97(1159):1243-1254. PubMed ID: 38730550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preoperative concurrent chemoradiotherapy MRI characteristics favouring pathologic complete response in patients with rectal cancer: Usefulness of MR T2-stage as an ancillary finding for predicting pathologic complete response.
    Lee HJ; Chung WS; An JH; Kim JH
    J Med Imaging Radiat Oncol; 2021 Apr; 65(2):166-174. PubMed ID: 33319450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the diagnostic performance of changes in signal intensity and volume from multiparametric MRI for assessing response of rectal cancer to neoadjuvant chemoradiotherapy.
    Tan Z; Cheng L; Xie L; Zhang L; Lin Z; Han P; Li X
    Asia Pac J Clin Oncol; 2023 Jun; 19(3):327-336. PubMed ID: 36271652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extracellular volume fraction determined by equilibrium contrast-enhanced CT for the prediction of the pathological complete response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Luo Y; Liu L; Liu D; Shen H; Wang X; Fan C; Zeng Z; Zhang J; Tan Y; Zhang X; Wu J; Zhang J
    Eur Radiol; 2023 Jun; 33(6):4042-4051. PubMed ID: 36462046
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer.
    Seierstad T; Hole KH; Grøholt KK; Dueland S; Ree AH; Flatmark K; Redalen KR
    Br J Radiol; 2015 Jul; 88(1051):20150097. PubMed ID: 25899892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical predictors of response to chemoradiotherapy for rectal cancer as an aid to organ preservation.
    Fischer J; Eglinton TW; Frizelle FA
    ANZ J Surg; 2021 Jun; 91(6):1190-1195. PubMed ID: 33404195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MR Imaging of Rectal Cancer: Radiomics Analysis to Assess Treatment Response after Neoadjuvant Therapy.
    Horvat N; Veeraraghavan H; Khan M; Blazic I; Zheng J; Capanu M; Sala E; Garcia-Aguilar J; Gollub MJ; Petkovska I
    Radiology; 2018 Jun; 287(3):833-843. PubMed ID: 29514017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy.
    Cui J; Yang L; Guo L; Shao Y; Tan D; Li N; Zhang H
    Oncotarget; 2017 Jun; 8(23):37845-37854. PubMed ID: 28103579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deep learning radiomics-based prediction of distant metastasis in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A multicentre study.
    Liu X; Zhang D; Liu Z; Li Z; Xie P; Sun K; Wei W; Dai W; Tang Z; Ding Y; Cai G; Tong T; Meng X; Tian J
    EBioMedicine; 2021 Jul; 69():103442. PubMed ID: 34157487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predicting locally advanced rectal cancer response to neoadjuvant therapy with
    Giannini V; Mazzetti S; Bertotto I; Chiarenza C; Cauda S; Delmastro E; Bracco C; Di Dia A; Leone F; Medico E; Pisacane A; Ribero D; Stasi M; Regge D
    Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):878-888. PubMed ID: 30637502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DCE-MRI time-intensity curve visual inspection to assess pathological response after neoadjuvant therapy in locally advanced rectal cancer.
    Petrillo A; Fusco R; Petrillo M; Granata V; Bianco F; Di Marzo M; Delrio P; Tatangelo F; Botti G; Pecori B; Avallone A
    Jpn J Radiol; 2018 Oct; 36(10):611-621. PubMed ID: 30039258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and biochemical predictors of tumor response after neoadjuvant therapy in rectal cancer.
    Bedrikovetski S; Traeger L; Vather R; Moore JW; Sammour T
    Asia Pac J Clin Oncol; 2023 Jun; 19(3):365-373. PubMed ID: 36305516
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Voxel-based dual-time 18F-FDG parametric imaging for rectal cancer: differentiation of residual tumor from postchemoradiotherapy changes.
    Choi H; Yoon HJ; Kim TS; Oh JH; Kim DY; Kim SK
    Nucl Med Commun; 2013 Dec; 34(12):1166-73. PubMed ID: 24128896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Performance of Machine Learning and Texture Analysis for Predicting Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer with 3T MRI.
    Bellini D; Carbone I; Rengo M; Vicini S; Panvini N; Caruso D; Iannicelli E; Tombolini V; Laghi A
    Tomography; 2022 Aug; 8(4):2059-2072. PubMed ID: 36006071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A prediction model of pathological complete response in patients with locally advanced rectal cancer after PD-1 antibody combined with total neoadjuvant chemoradiotherapy based on MRI radiomics].
    Zhang XY; Zhu HT; Li XT; Li YJ; Li ZW; Wang WH; Wu AW; Sun YS; Zhang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):228-234. PubMed ID: 35340172
    [No Abstract]   [Full Text] [Related]  

  • 60. Mutation in BRAF and SMAD4 associated with resistance to neoadjuvant chemoradiation therapy in locally advanced rectal cancer.
    Jiang D; Wang X; Wang Y; Philips D; Meng W; Xiong M; Zhao J; Sun L; He D; Li K
    Virchows Arch; 2019 Jul; 475(1):39-47. PubMed ID: 31056731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.